Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2025 Jun 12;45(1):245.
doi: 10.1007/s10792-025-03616-0.

Impact of residual ophthalmic viscosurgical device behind intraocular lens on postoperative intraocular pressure and refractive outcomes in cataract surgery

Affiliations
Clinical Trial

Impact of residual ophthalmic viscosurgical device behind intraocular lens on postoperative intraocular pressure and refractive outcomes in cataract surgery

Omer M Bilgic et al. Int Ophthalmol. .

Abstract

Purpose: This study aims to quantify the residual ophthalmic viscosurgical device (OVD) behind the intraocular lens (IOL) following cataract surgery and evaluate its impact on intraocular pressure (IOP) and refractive changes during the postoperative period. Additionally, it examines OVD regression and associated risk factors.

Design: Prospective Clinical Trial.

Methods: Thirty eyes of thirty patients who underwent uncomplicated cataract surgery with monofocal posterior chamber IOL implantation were included. Postoperative assessments were conducted on days 1, 3, 5, 7, 10, and 14. Using anterior segment OCT, OVD thickness behind the IOL was measured, and correlations were analyzed between OVD reduction, IOP (via non-contact tonometry), and refractive error changes. Risk factors examined included age, gender, laterality, pseudoexfoliation (psx), surgeon experience, cataract hardness, biometric data, and phacoemulsification parameters.

Results: On day 1, mean OVD thickness was 215.7 ± 92.7 µm. A significant decrease in OVD was noted with each follow-up, with complete resorption by day 10 (p = 0.01). Initial IOP was 18.0 ± 3.3 mmHg, showing a notable reduction over time (p = 0.01). A positive correlation was observed between OVD reduction and IOP decrease from days 1 to 3 (p = 0.01, r = 0.581) and days 1 to 5 (p = 0.017, r = 0.432). Additionally, a significant association was found between OVD reduction and myopic shift from days 3 to 5 (p = 0.014, r = 0.444). Patients with thinner lenses had higher residual OVD on day 1 (p = 0.01, r = - 0.504).

Conclusions: Residual OVD behind the IOL may elevate IOP and cause refractive changes, emphasizing the need for thorough OVD removal and close postoperative monitoring, especially in patients with thinner lenses.

Keywords: Anterior segment optical coherence tomography; Intraocular pressure; Ophthalmic viscosurgical devices; Phacoemulsification; Refraction.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests.

References

    1. de Silva SR, Riaz Y, Evans JR (2014) Phacoemulsification with posterior chamber intraocular lens versus extracapsular cataract extraction (ECCE) with posterior chamber intraocular lens for age-related cataract. Cochrane Database Syst Rev 2014(1):CD008812. https://doi.org/10.1002/14651858.CD008812.pub2 - DOI - PubMed - PMC
    1. Gurnani B, Kaur K (2023) Phacoemulsification. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island
    1. Egorova AV, Vasiliev AV, Bai L (2021) Influence of the quality of viscoelastic removal on phacoemulsification results. Part 2 Dependence of “IOL—posterior lens capsule” interface status on viscoelastic visualization. Ophthalmol Rep 14(4):13–18. https://doi.org/10.17816/OV79226 - DOI
    1. Higashide T, Sugiyama K (2008) Use of viscoelastic substance in ophthalmic surgery—focus on sodium hyaluronate. Clin Ophthalmol 2:21–30 - DOI - PubMed - PMC
    1. Gunji H, Ohki T (2019) Quantification of residual ophthalmic viscosurgical device after irrigation/aspiration in experimental cataract surgery in vitro. J Cataract Refract Surg 45(9):1324–1329. https://doi.org/10.1016/j.jcrs.2019.03.025 - DOI - PubMed

Publication types

LinkOut - more resources